New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

Bravo TV host Andy Cohen told the TODAY show that microdosing a GLP-1 drug helped him lose “a good chunk of weight.” The ...

How it began: When Valley Plaza opened in 1951, it was right when the shopping experience was changing. The developer behind ...

Eli Lilly on Friday crossed the $1 trillion market-cap threshold, becoming the first drugmaker to ever reach that milestone.

Nausea, a major hurdle for millions using weight-loss drugs like Ozempic, may soon be a thing of the past. Researchers are ...

GLP-1 RAs are associated with a 62% reduction in 5-year mortality in colon cancer patients, especially those with high obesity. The study's findings remained significant after adjusting for ...

Millions of Americans have successfully lost weight using drugs like Wegovy and Zepbound, but unpleasant side ...

By 2030, households with GLP-1 users are projected to represent 35% of all food and beverage units sold, the consumer ...

Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) use was significantly associated with a reduced odds of five-year mortality, but this protective effect was found to be statistically significant ...

Lilly’s (LLY) recent climb to reach a $1T market cap will come under scrutiny in the coming days when Novo Nordisk (NVO) ...

NBC News' Anne Thompson joins "Here's the Scoop" co-host Yasmin Vossoughian to talk about why some people are microdosing GLP ...

A possible workaround came from a team led by Ernie Blevins of the University of Washington. They gave obese rats a low dose ...